Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
103
NCT05010759
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer
Phase: N/A
Role: Lead Sponsor
Start: Nov 30, 2021
Completion: Jul 28, 2023
NCT06271421
NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
Role: Collaborator
Start: Jan 1, 2024
Completion: Sep 1, 2027